Skip to content

Effects of yeast drink intake on GI value

Effects of yeast drink intake on GI value - Effects of yeast drink intake on GI value

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035727
Enrollment
12
Registered
2019-02-01
Start date
2019-02-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Eat 150g retort rice (cooked rice by Sato food koshihikari-100% natural made in Niigata) as a control. Take a diluted yeast drink (1/6 or 1/7 dilution from a 64ml concentrated yeast drink with water)

Sponsors

IMEQRD Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.20 to 49 years old (at the time of submission of an informed consent document). 2. Healthy adults ("Healthy" is defined as those who currently have neither severe organ damage nor a particular disease, those who currently do not receive treatment associated with the above disorders, and those who currently do not receive any kind of drug treatment. The principal investigator judges whether or not a candidate meets this definition according to the self-report submitted when a clinical trial is commenced). 3. Males and females. 4. Body mass index (BMI) of 30 kg/m2 or lower. 5. Those who have not been diagnosed with impaired glucose tolerance over the past one year. 6. Those who can abstain from foods that affect intestinal bacteria, such as yeast-containing foods, yogurt, probiotic fermented foods, and foods for specified health use while participating in this clinical trial. 7. Those who do not change or those who are not planning to change their lifestyles while participating in this clinical trial. 8. Those who can provide their written informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who currently receive treatment with some types of drugs and Chinese herbal medicines (except for the drugs that are taken as needed). 2. Those with a past medical history of treatment for heart failure, heart attack, etc. 3. Those who have undergone gastrointestinal surgery (except for appendectomy). 4. Those with a past medical history of any of the following: hepatic or other major disorders (kidneys, endocrine, cardiovascular, gastrointestine, lungs, blood, and metabolism), or complications of the disorders listed above. (Those who are in treatment for atrial fibrillation, arrhythmia, hepatic or renal impairment, cerebrovascular disease, rheumatism, diabetes, dyslipidemia, hypertension, or other chronic diseases). 5. D criteria for comprehensive medical examination (D stands for "requiring medical treatment"). Except for a value within the range of two standard errors judged by a physician. 6. Those who currently take health foods (including food products to maintain or restore health, supplements, etc.). 7. Those with a past and current medical history of drug or food allergy. 8. Those who are currently participating in another clinical trial or those who participated in another clinical trial within a month prior to submission of an informed consent document. 9. Those who are currently pregnant or breastfeeding and those who desire a pregnancy. 10. In the opinion of the principal investigator, those who were determined to be unsuitable for participation in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Blood glucose level and GI value

Countries

Japan

Contacts

Public ContactYoshitada Hira

IMEQRD Co., Ltd Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026